Sichuan Biokin Pharmaceutical Co., Ltd.SSE: 688506

Announcement on Convening the Q3 2025 Performance Briefing

Nov 28, 2025 · Issued by Sichuan Biokin Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Nov 28, 2025

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2025-performance-briefing-797

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Sichuan Biokin Pharmaceutical Co., Ltd. on 6ix

Earlier from Sichuan Biokin Pharmaceutical

Announcement on Voluntary Disclosure of the Acceptance of the New Drug Application for Iza-Bren (an EGFR×HER3 Bispecific Antibody-Drug Conjugate) for the Treatment of Locally Advanced or Metastatic Nasopharyngeal CarcinomaNov 24, 2025
Announcement on Signing Strategic Cooperation Agreement with Bank of China Limited, Sichuan BranchNov 20, 2025
Announcement on Resolutions of the 3rd Meeting of the 5th Board of DirectorsNov 5, 2025
Announcement on Replacing Self-raised Funds Invested in Advance in Investment Projects Financed by Raised Funds and Paid for Issuance Fee with Raised FundsOct 27, 2025
Largest Milestone Payment Secured: Biokin, a Rising Chinese Pharmaceutical MNCOct 22, 2025

Later from Sichuan Biokin Pharmaceutical

Announcement on Voluntary Disclosure of Milestone Payment Received by Wholly-owned Subsidiary Systimmune and Bristol-Myers Squibb for the Global Strategic Cooperation Agreement of iza-brenDec 1, 2025
Announcement on Proposed Application for Registration and Issuance of Debt Financing InstrumentsDec 29, 2025
Announcement on Resolutions of the 5th Meeting of the 5th Board of DirectorsDec 31, 2025
Announcement on Voluntary Disclosure of Inclusion of iza-bren (EGFR×HER3 Bispecific ADC) for the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma into the Priority Review ProgramJan 7
Biokin to Present at J.P. Morgan's 44th Annual Healthcare ConferenceJan 13

All Sichuan Biokin Pharmaceutical news releases

Follow Sichuan Biokin Pharmaceutical into a list and get an email when it puts out news.

Follow Sichuan Biokin Pharmaceutical